Endpoint definition
↥Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
conjunctivitis: Inflammation of the conjunctiva of the eye. [ NCIT:P378 ]
Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis) based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 12606 | 9750 | 2856 |
Unadjusted prevalence (%) | 4.85 | 6.63 | 2.53 |
Mean age at first event (years) | 39.09 | 39.80 | 36.68 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.01 | 0.99 [0.76, 1.30] | 9.5e-1 | 357 |
15 years | 0.01 | 1.11 [0.87, 1.43] | 3.9e-1 | 245 |
5 years | 0.00 | 1.24 [0.90, 1.71] | 1.8e-1 | 62 |
1 year | - | - | - | - |
Index endpoint: H7_USEOFEYEANTIALLERGENS – Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
GWS hits: 7
before Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
Loading survival analyses plot
Loading survival analyses table